Mirae Asset Pharma Fund - Regular Plan - Growth

Mirae Asset Pharma Fund - Regular Plan - Growth overview and fund details

Mirae Asset Pharma Fund - Regular Plan - Growth ek equity mutual fund hai jo specifically pharmaceutical sector mein invest karta hai. Iska objective hai long-term capital growth achieve karna through diversified portfolio of pharma companies. Agar aap healthcare aur pharma sector ki growth potential par vishwas rakhte hain, toh yeh fund aapke liye suitable ho sakta hai. Yeh fund high growth potential ke liye jaana jaata hai, lekin ismein market volatility bhi hoti hai. Isliye, yeh un investors ke liye acha hai jo high risk tolerance rakhte hain aur long-term investing mein interested hain. Fund ka AUM ₹3636 Cr hai aur expense ratio 1.95% hai, jo iski operational efficiency ko darshata hai.

Mirae Asset Pharma Fund - Regular Plan - Growth returns analysis 2026

Mirae Asset Pharma Fund - Regular Plan - Growth ne last 1 saal mein 2.41% ka return diya hai. Iski 3 saal ki CAGR returns 12.03% hai, jo overall achi consistency darshata hai. Lekin, 5 saal ka return 0% hai, jo thoda disappointing hai. Yeh fund Nifty Pharma TRI benchmark se compare karne par bhi kuch challenges face karta hai, lekin iska focus long-term growth par hai.

Period	Mirae Asset Pharma Fund - Regular Plan - Growth Returns	Benchmark Returns (Nifty Pharma TRI)
1 Year	2.41%	Data not available
3 Year	12.03%	Data not available
5 Year	0%	Data not available

Yeh fund Gaurav Khandelwal ke under manage hota hai, jinka tenure 3.5 saal hai. Fund manager ka experience aur stock selection strategies fund ke performance par significant impact dalte hain. Isliye, investors ko unki strategies ko samajhna zaroori hai, taaki wo informed decisions le sakain.

Mirae Asset Pharma Fund - Regular Plan - Growth top holdings and portfolio allocation

Mirae Asset Pharma Fund - Regular Plan - Growth ki top holdings mein Sun Pharmaceutical Industries Ltd. (20.5%), Dr. Reddy's Laboratories Ltd. (12.8%), Cipla Ltd. (10.4%), Divi's Laboratories Ltd. (9.8%), aur Torrent Pharmaceuticals Ltd. (7.2%) shamil hain. Is fund mein sector allocation primarily pharma companies mein hai, jo ki fund ki strategy se bilkul align karta hai. Yeh fund apne portfolio ko diversify karte hue major pharmaceutical players mein invest karta hai, jisse investors ko sector-specific growth ka fayda milta hai. Agar aap pharma sector ki growth potential ko dekh rahe hain, toh yeh fund aapke portfolio ke liye ek acha addition ho sakta hai. Portfolio diversification se aap risk ko manage kar sakte hain, kyunki pharma sector ki performance dusre sectors se alag hoti hai.

Mirae Asset Pharma Fund - Regular Plan - Growth – risk level aur volatility

Mirae Asset Pharma Fund - Regular Plan - Growth ka riskometer "Very High" dikhata hai, jo iska high volatility aur potential market risks ko darshata hai. Yeh fund un investors ke liye suitable hai jo risk le sakte hain aur long-term capital growth ke liye tayar hain. Volatility ke kaaran, investor ko is fund mein investment karne se pehle apne financial goals aur risk tolerance ka dhyaan rakhna zaroori hai. Agar aap ek conservative investor hain, toh yeh fund aapke liye sahi nahi ho sakta. Lekin agar aap aggressive growth ki talash mein hain, toh yeh fund aapko higher returns ka potential de sakta hai.

Mirae Asset Pharma Fund - Regular Plan - Growth advantages and disadvantages

• Pros:
• 1. Strong sector focus on pharmaceuticals.
• 2. Potential for high growth returns.
• 3. Experienced fund manager with a good track record.
• 4. Diversification within the pharma sector.

• Cons:
• 1. High volatility and risk levels.
• 2. Recent 5Y returns of 0% are concerning.
• 3. Expense ratio of 1.95% is relatively high.